BBS-Bioactive Bone Substitutes PLC

OHEL:BONEH (Finland)   Ordinary Shares
€ 0.42 (+6.92%) Jun 12
At Loss
P/B:
1.58
Market Cap:
€ 8.46M ($ 9.09M)
Enterprise V:
€ 11.24M ($ 12.08M)
Volume:
29.42K
Avg Vol (2M):
48.72K
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for BBS-Bioactive Bone Substitutes PLC ( ) from 2018 to Jun 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. BBS-Bioactive Bone Substitutes PLC stock (OHEL:BONEH) PE ratio as of Jun 13 2024 is 0. More Details

BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) PE Ratio (TTM) Chart

To

BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) PE Ratio (TTM) Historical Data

Total 1287
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
BBS-Bioactive Bone Substitutes PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-13 At Loss 2024-04-09 At Loss
2024-06-12 At Loss 2024-04-08 At Loss
2024-06-11 At Loss 2024-04-05 At Loss
2024-06-10 At Loss 2024-04-04 At Loss
2024-06-07 At Loss 2024-04-03 At Loss
2024-06-06 At Loss 2024-04-02 At Loss
2024-06-05 At Loss 2024-03-28 At Loss
2024-06-04 At Loss 2024-03-27 At Loss
2024-06-03 At Loss 2024-03-26 At Loss
2024-05-31 At Loss 2024-03-25 At Loss
2024-05-30 At Loss 2024-03-22 At Loss
2024-05-29 At Loss 2024-03-21 At Loss
2024-05-28 At Loss 2024-03-20 At Loss
2024-05-27 At Loss 2024-03-19 At Loss
2024-05-24 At Loss 2024-03-18 At Loss
2024-05-23 At Loss 2024-03-15 At Loss
2024-05-22 At Loss 2024-03-14 At Loss
2024-05-21 At Loss 2024-03-13 At Loss
2024-05-20 At Loss 2024-03-12 At Loss
2024-05-17 At Loss 2024-03-11 At Loss
2024-05-16 At Loss 2024-03-08 At Loss
2024-05-15 At Loss 2024-03-07 At Loss
2024-05-14 At Loss 2024-03-06 At Loss
2024-05-13 At Loss 2024-03-05 At Loss
2024-05-10 At Loss 2024-03-04 At Loss
2024-05-08 At Loss 2024-03-01 At Loss
2024-05-07 At Loss 2024-02-29 At Loss
2024-05-06 At Loss 2024-02-28 At Loss
2024-05-03 At Loss 2024-02-27 At Loss
2024-05-02 At Loss 2024-02-26 At Loss
2024-04-30 At Loss 2024-02-23 At Loss
2024-04-29 At Loss 2024-02-22 At Loss
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-16 At Loss
2024-04-22 At Loss 2024-02-15 At Loss
2024-04-19 At Loss 2024-02-14 At Loss
2024-04-18 At Loss 2024-02-13 At Loss
2024-04-17 At Loss 2024-02-12 At Loss
2024-04-16 At Loss 2024-02-09 At Loss
2024-04-15 At Loss 2024-02-08 At Loss
2024-04-12 At Loss 2024-02-07 At Loss
2024-04-11 At Loss 2024-02-06 At Loss
2024-04-10 At Loss 2024-02-05 At Loss

BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

BBS-Bioactive Bone Substitutes PLC

ISIN : FI4000260583

Share Class Description:

OHEL:BONEH: Ordinary Shares
Description
BBS-Bioactive Bone Substitutes PLC) is a biomedical technology company that develops, manufactures, and commercializes innovative, bioactive medical devices and implants for orthopaedic surgery, and develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.